4-Methylpyrazole ( DrugBank: 4-methylpyrazole )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
301黄斑ジストロフィー1

301. 黄斑ジストロフィー


臨床試験数 : 45 薬物数 : 46 - (DrugBank : 12) / 標的遺伝子数 : 9 - 標的パスウェイ数 : 67
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00346853
(ClinicalTrials.gov)
November 200528/6/2006Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular DystrophyClinical Interventions Against Stargardt Macular Dystrophy: Phase 1 Pilot Study of 4-MP as an Inhibitor of Dark AdaptationMacular Dystrophy, CornealDrug: 4-Methylpyrazole;Other: salineUniversity of UtahNULLCompleted18 Years65 YearsAll10Phase 1United States